Heron Therapeutics reported $-62281000 in Pre-Tax Profit for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Adamas Pharmaceuticals ADMS:US -12573000 5.7M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -199.28M 44.32M
Amarin AMRN:US $ -1M 8.6M
Ani Pharmaceuticals ANIP:US $ 15.06M 0M
Anika Therapeutics ANIK:US $ 1.22M 19.35M
Arrowhead Research ARWR:US $ -26.82M 6.09M
Eisai 4523:JP Y -5805M 29729M
Endo International Ordinary Shares ENDP:US $ 204.17M 13.97M
Esperion Therapeutics ESPR:US $ -90935000 13.54M
Flexion Therapeutics FLXN:US $ -28556000 8.91M
GlaxoSmithKline GSK:LN 1482M 225M
Immunogen IMGN:US $ -30.74M 3.31M
Insmed INSM:US $ -91402000 10.19M
Ligand Pharmaceuticals LGND:US $ 34.99M 4.55M
Neurocrine Biosciences NBIX:US $ 27.2M 32.9M
Omeros OMER:US $ -35090000 6.34M
Sangamo Biosciences SGMO:US $ -45.68M 5.11M
Ultragenyx Pharmaceutical RARE:US $ -135.76M 111.82M
Veracyte VCYT:US $ 9.19M 19.75M